You are here: Industry Insights > MSC

News List

AG Nessel Launches Investigation into Excessive Insulin Prices, Intends to Challenge MSC Decisions Impacting Consumer Protection FirstWordPharma
January 28, 2022
Michigan Attorney General Dana Nessel launched an investigation into Eli Lilly this week - one of the three largest drug companies that manufactures nearly all the insulin in the United States.
PBS Biotech secures $10 million to expand cell therapy manufacturing equipment portfolio cphi-online
August 19, 2021
The capital will be used to expand and industrialise the company's range of single-use bioreactor systems and contract process development services
Stem cell transplantation may be able to prevent major cause of death in preterm infants europeanpharmaceuticalreview
April 22, 2021
Transplanting stem cells directly into the trachea of preterm infants with bronchopulmonary dysplasia was found to be safe and of some benefit in the most vulnerable group.
Bone Therapeutics, Rigenerand Ink Cell Therapy Deal contractpharma
January 20, 2021
Bone Therapeutics, a cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Rigenerand SRL, a biotech company that both develops and manufactures medicinal products for cell therapy applications, primarily for ...
Novel gelatin microcarrier developed to enhance cell production europeanpharmaceuticalreview
November 06, 2020
Researchers who developed the dissolvable microcarrier for large-scale cell production and expansion say it offers higher yield and cost-effectiveness compared to traditional methods.
Microneedle system developed to deliver mesenchymal stem cells europeanpharmaceuticalreview
June 15, 2020
A group of researchers has developed a microneedle delivery system for mesenchymal stem cells, which showed success in mice skin wound models.
Lonza acquires controlling stake in Octane Biotech to further develop Cocoon autologous technology cphi-online
November 05, 2018
Acquisition further strengthens Lonza’s commitment to drive the next generation of manufacturing patient-specific and personalized therapies...